A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis1
暂无分享,去创建一个
[1] J. Sprent,et al. Lifespan of lymphocytes , 1995, Immunologic research.
[2] H. Gan,et al. Interleukin 10 produced by macrophages inoculated with Mycobacterium avium attenuates mycobacteria-induced apoptosis by reduction of TNF-alpha activity. , 1999, The Journal of infectious diseases.
[3] Malin,et al. Human cytolytic and interferon g-secreting CD 8 1 T lymphocytes specific for Mycobacterium tuberculosis , 1997 .
[4] R. Young,et al. Increased Antimycobacterial Immunity in Interleukin-10-Deficient Mice , 1999, Infection and Immunity.
[5] S. Giosué,et al. Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. , 1999, American journal of respiratory and critical care medicine.
[6] S. Kira,et al. Prognostic value of Ia+ T lymphocytes in bronchoalveolar lavage fluid in pulmonary sarcoidosis. , 1996, American journal of respiratory and critical care medicine.
[7] P. Schlesinger,et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. , 1994, Science.
[8] B. Samten,et al. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. , 1999, The Journal of infectious diseases.
[9] S. Reed,et al. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. , 1998, Journal of immunology.
[10] V. Maino,et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations , 1995, The Journal of experimental medicine.
[11] G. V. van Seventer,et al. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals. , 1997, Journal of immunology.
[12] E. Radwanski,et al. Pharmacodynamics of subcutaneous recombinant human interleukin‐10 in healthy volunteers , 1997, Clinical pharmacology and therapeutics.
[13] J. Abrams,et al. Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.
[14] N. Rao,et al. Yield of gastric lavage and bronchial wash in pulmonary tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[15] J. Ho,et al. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. , 1998, Journal of immunology.
[16] A. Scheffold,et al. Commitment of individual Th1-like lymphocytes to expression of IFN-gamma versus IL-4 and IL-10: selective induction of IL-10 by sequential stimulation of naive Th cells with IL-12 and IL-4. , 1998, Journal of immunology.
[17] R. de Waal Malefyt,et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. , 1992, Journal of immunology.
[18] A S Perelson,et al. Role of the thymus in pediatric HIV-1 infection. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[19] R. Kurzrock,et al. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. , 1985, Cancer research.
[20] Z. Toossi,et al. Regulation of Interleukin-12 by Interleukin-10, Transforming Growth Factor-β, Tumor Necrosis Factor-α, and Interferon-γ in Human Monocytes Infected with Mycobacterium tuberculosis H37Ra , 1998 .
[21] M. de Carli,et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. , 1993, Journal of immunology.
[22] B. Hamilton,et al. Interaction of Mycobacterium tuberculosis-Induced Transforming Growth Factor β1 and Interleukin-10 , 1999, Infection and Immunity.
[23] I. Orme,et al. Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.
[24] H. Dockrell,et al. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Blaser,et al. Theoretical and experimental approaches for studying factors defining the Helicobacter pylori-host relationship. , 2000, Trends in microbiology.
[26] P. Haslett,et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. , 1999, Journal of immunology.
[27] B. Hemmer,et al. Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis. , 1997, Journal of immunology.
[28] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[29] A. Izzo,et al. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity , 1993, The Journal of experimental medicine.
[30] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[31] K. Croitoru,et al. Protection by CD4 or CD8 T Cells against PulmonaryMycobacterium bovis Bacillus Calmette-Guérin Infection , 1998, Infection and Immunity.
[32] J. Flynn,et al. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.
[33] C. Lowenstein,et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.
[34] W. Boom,et al. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. , 1997, Journal of immunology.
[35] F. Miedema,et al. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. , 1996, Journal of immunology.
[36] C. Figdor,et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.
[37] G. Puzo,et al. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. , 1997, Journal of immunology.
[38] G. Galluccio,et al. Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis. , 1998, American journal of respiratory and critical care medicine.
[39] C. Mody,et al. Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages. , 1999, American journal of respiratory and critical care medicine.
[40] J. Wang,et al. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice. , 1998, Journal of immunology.
[41] S. Kaufmann,et al. Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages , 1997, Infection and immunity.
[42] U. Lalloo,et al. Correlation of CD4:CD8 ratio and tumour necrosis factor (TNF)α levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis , 2000, Thorax.
[43] S. Kunkel,et al. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. , 1995, Journal of immunology.
[44] W. Rom,et al. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. , 1996, American journal of respiratory and critical care medicine.
[45] S. Kaufmann,et al. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor , 1990, Infection and immunity.
[46] M. Blaser,et al. Persistent bacterial infections , 2000 .
[47] J. Sprent. Lifespans of naive, memory and effector lymphocytes. , 1993, Current opinion in immunology.
[48] C. Janeway. Immunobiology: The Immune System in Health and Disease , 1996 .
[49] M. Olivier,et al. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. , 1999, Journal of immunology.
[50] R. Flavell,et al. Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. , 1997, Journal of immunology.
[51] G. Trinchieri,et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.
[52] J. Keane,et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis , 1997, Infection and immunity.
[53] P. Morel,et al. Modeling the proliferative response of T cells to IL-2 and IL-4. , 1997, Cellular immunology.
[54] P. Barnes,et al. Growth of Virulent and AvirulentMycobacterium tuberculosis Strains in Human Macrophages , 1998, Infection and Immunity.
[55] J. Banchereau,et al. Interferon gamma inhibits interleukin 10 production by monocytes , 1993, The Journal of experimental medicine.
[56] Sergei S. Pilyugin,et al. Modeling immune responses with handling time , 2000, Bulletin of mathematical biology.
[57] Norman L. Cressy. The Tubercle Bacillus in the Pulmonary Lesion of Man , 1955, The Yale Journal of Biology and Medicine.
[58] E. Block,et al. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. , 1990, The American review of respiratory disease.
[59] C. Ellis,et al. Specific lysis of mycobacterial antigen‐bearing macrophages by class II MHC‐restricted polyclonal T cell lines in healthy donors or patients with tuberculosis , 1990, Clinical and experimental immunology.
[60] R. North. Mice incapable of making IL‐4 or IL‐10 display normal resistance to infection with Mycobacterium tuberculosis , 1998, Clinical and experimental immunology.
[61] A. Sher,et al. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.
[62] P. Linsley,et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression , 1996, Infection and immunity.
[63] S. Meddows-Taylor,et al. Dysregulated Production of Interleukin-8 in Individuals Infected with Human Immunodeficiency Virus Type 1 andMycobacterium tuberculosis , 1999, Infection and Immunity.
[64] P. Barnes,et al. Absence of a prominent Th2 cytokine response in human tuberculosis , 1996, Infection and immunity.
[65] W. Rom,et al. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. , 1996, American journal of respiratory and critical care medicine.
[66] C. Nathan,et al. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.
[67] M Juchniewicz,et al. [Epidemiology of tuberculosis]. , 1970, Pielegniarka i polozna.
[68] M. Newport,et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.
[69] R. Young,et al. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. , 1997, Journal of immunology.
[70] R. Stout,et al. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. , 1989, Journal of immunology.
[71] B. Bloom,et al. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages , 1993 .
[72] D. Remick,et al. Cytokines in Health and Disease , 1992 .
[73] G. Trinchieri,et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.
[74] G. Kaplan,et al. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. , 1996, The Journal of infectious diseases.
[75] G. Trinchieri,et al. CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .
[76] 马建新,et al. 用FEV6.0代替FVC诊断气道阻塞和肺功能受限[英]/Swanney MP…∥Am J Respir Crit Care Med. , 2002 .
[77] J. Ceuppens,et al. Interleukin 12 and B7/CD28 interaction synergistically upregulate interleukin 10 production by human T cells. , 1997, Cytokine.
[78] W. Rom,et al. Local immune responses correlate with presentation and outcome in tuberculosis. , 1998, American journal of respiratory and critical care medicine.
[79] P. Bardin,et al. In Situ Production of Gamma Interferon, Interleukin-4, and Tumor Necrosis Factor Alpha mRNA in Human Lung Tuberculous Granulomas , 2000, Infection and Immunity.
[80] Z. Toossi,et al. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. , 1998, American journal of respiratory cell and molecular biology.
[81] J. Blanchard,et al. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. , 1999, Journal of immunology.
[82] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[83] G. Rook,et al. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. , 2000, The Journal of infectious diseases.
[84] J. D. de Vries,et al. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level , 1996, The Journal of experimental medicine.
[85] G. Ainslie,et al. Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery. , 1992, Thorax.
[86] A S Perelson,et al. Th1/Th2 cross regulation. , 1993, Journal of theoretical biology.
[87] B. Bloom,et al. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages , 1993, Infection and immunity.
[88] Y. Luo,et al. Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guérin. , 1999, Journal of immunology.
[89] J. Ellner,et al. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects. , 1998, Journal of immunology.
[90] H. Macdonald,et al. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. , 1998, Journal of immunology.
[91] E. Radwanski,et al. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. , 1996, Blood.
[92] M. Gately,et al. Interleukin 12 at the site of disease in tuberculosis. , 1994, The Journal of clinical investigation.
[93] M. Burdick,et al. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. , 1993, Journal of immunology.
[94] M. de Carli,et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. , 1992, Journal of immunology.
[95] J. Ellner,et al. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. , 1994, Journal of immunology.
[96] J. Sedgwick,et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. , 1999, Journal of immunology.
[97] P. Gros,et al. Consequence of Nramp1 Deletion toMycobacterium tuberculosis Infection in Mice , 1999, Infection and Immunity.
[98] Glenn F. Webb,et al. Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4+ lymphocytes. , 2000 .
[99] D. Kirschner,et al. Dynamics of co-infection with M. Tuberculosis and HIV-1. , 1999, Theoretical population biology.
[100] F. Deist,et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.
[101] J. Abrams,et al. T-cell cytokine responses in human infection with Mycobacterium tuberculosis , 1995, Infection and immunity.
[102] J. Meer,et al. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. , 2000, The Journal of infectious diseases.
[103] M. Torres,et al. Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. , 1998, The Journal of infectious diseases.
[104] J. Keane,et al. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. , 1998, Journal of immunology.
[105] B. Bloom,et al. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.
[106] H. Dockrell,et al. Characterization of Human Mycobacterium bovis Bacille Calmette-Guérin-Reactive CD8+T Cells , 1999, Infection and Immunity.
[107] M. Newport,et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.
[108] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.
[109] D. Kirschner,et al. Mathematical Models of Colonization and Persistence in Bacterial Infections , 2000 .
[110] F. Balkwill. Cytokines in health and disease. , 1993, Immunology today.
[111] J. Flynn,et al. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. , 1995, Journal of immunology.
[112] P. Schlesinger,et al. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. , 1998, Journal of immunology.
[113] Savageau Ma,et al. Reconstructionist molecular biology. , 1991 .
[114] W. Boom,et al. CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. , 1995, Journal of immunology.
[115] J. Flynn,et al. Reactivation of Latent Tuberculosis: Variations on the Cornell Murine Model , 1999, Infection and Immunity.
[116] J. Flynn,et al. Early Emergence of CD8+ T Cells Primed for Production of Type 1 Cytokines in the Lungs of Mycobacterium tuberculosis-Infected Mice , 1999, Infection and Immunity.
[117] R. Kurzrock,et al. Pharmacokinetics, Single-Dose Tolerance, and Biological Activity of Recombinant γ-lnterferon in Cancer Patients , 1985 .
[118] Hardy Kornfeld,et al. Virulent Mycobacterium tuberculosis Strains Evade Apoptosis of Infected Alveolar Macrophages1 , 2000, The Journal of Immunology.
[119] J. Abrams,et al. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. , 1993, Journal of immunology.
[120] T. Mosmann,et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.
[121] J. Ellner,et al. Expression of Virulence of Mycobacterium tuberculosiswithin Human Monocytes: Virulence Correlates with Intracellular Growth and Induction of Tumor Necrosis Factor Alpha but Not with Evasion of Lymphocyte-Dependent Monocyte Effector Functions , 1998, Infection and Immunity.
[122] J. Flynn,et al. CD8+ CTL from Lungs of Mycobacterium tuberculosis-Infected Mice Express Perforin In Vivo and Lyse Infected Macrophages1 , 2000, The Journal of Immunology.
[123] T. Kotsimbos,et al. IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. , 1997, American journal of respiratory and critical care medicine.
[124] P. D. Hart,et al. RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES , 1971, The Journal of experimental medicine.
[125] M A Savageau,et al. Reconstructionist molecular biology. , 1991, The New biologist.
[126] W. Boom,et al. Differential Regulation of IFN-γ, TNF-α, and IL-10 Production by CD4+ αβTCR+ T Cells and Vδ2+ γδ T Cells in Response to Monocytes Infected with Mycobacterium tuberculosis-H37Ra , 1999 .
[127] L. Segel,et al. On the role of feedback in promoting conflicting goals of the adaptive immune system. , 1999, Journal of immunology.
[128] M. Piacentini,et al. APOPTOSIS OF HUMAN MONOCYTES/MACROPHAGES IN MYCOBACTERIUM TUBERCULOSIS INFECTION , 1997, The Journal of pathology.
[129] L. Nicod,et al. Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10. , 1999, American journal of respiratory cell and molecular biology.
[130] A. O’Garra,et al. Cytokines induce the development of functionally heterogeneous T helper cell subsets. , 1998, Immunity.
[131] J. Watson,et al. Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis , 1997, Infection and immunity.
[132] J. Neefjes,et al. Interleukin-10 Down-Regulates MHC Class II αβ Peptide Complexes at the Plasma Membrane of Monocytes by Affecting Arrival and Recycling , 1997 .
[133] Sato,et al. Differential potentiation of anti‐mycobacterial activity and reactive nitrogen intermediate‐producing ability of murine peritoneal macrophages activated by interferon‐gamma (IFN‐γ) and tumour necrosis factor‐alpha (TNF‐α) , 1998, Clinical and experimental immunology.
[134] W. Boom,et al. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis , 1996, Infection and immunity.
[135] R. van Furth,et al. QUANTITATIVE STUDY ON THE PRODUCTION AND KINETICS OF MONONUCLEAR PHAGOCYTES DURING AN ACUTE INFLAMMATORY REACTION , 1973, The Journal of experimental medicine.
[136] J. Sprent,et al. Circulating T and B lymphocytes of the mouse. II. Lifespan. , 1973, Cellular immunology.
[137] Q. Myrvik,et al. Disruption of phagosomal membranes of normal alveolar macrophages by the H37Rv strain of Mycobacterium tuberculosis. A correlate of virulence. , 1984, The American review of respiratory disease.